High costs dim prospects for pharma firms shifting manufacturing to US - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Breaking

Post Top Ad

Post Top Ad

High costs dim prospects for pharma firms shifting manufacturing to US

Brokerages also felt that the pharma companies will aim to pass on the tariff hike to payors


Post Top Ad